Cabozantinib + nivolumab in adult patients with advanced or metastatic renal cell carcinoma: A retrospective, non-interventional study in a real-world cohort.

Authors

null

Thomas Hilser

Universitätsklinikum Essen (AöR), Westdeutsches Tumorzentrum Essen, Innere Klinik (Tumorforschung), Essen, Germany

Thomas Hilser , Christopher Darr , Guenter Niegisch , Marco Julius Schnabel , Susan Foller , Lorine Haeuser , Stefanie Zschaebitz , Jonas Lewerich , Merle Anders-Meyn , Philipp Ivanyi , Katrin Schlack , Viktor Grünwald

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers

Track

Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer

Sub Track

Quality of Care/Quality Improvement and Real-World Evidence

Citation

J Clin Oncol 41, 2023 (suppl 6; abstr 628)

DOI

10.1200/JCO.2023.41.6_suppl.628

Abstract #

628

Poster Bd #

E18

Abstract Disclosures